Detalhe da pesquisa
1.
[Early detection of prostate cancer: Towards a new paradigm?] / Détection précoce du cancer de la prostate : vers un nouveau paradigme ?
Prog Urol
; 33(15-16): 956-965, 2023 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-37805291
2.
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]. / Recherche d'altérations des gènes de réparation de l'ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l'association française d'urologie.
Prog Urol
; 32(3): 155-164, 2022 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-35125317
3.
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Prog Urol
; 32(15): 1275-1372, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400483
4.
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance.
Prog Urol
; 32(15): 1373-1419, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400484
5.
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]. / Avancées récentes dans la prise en charge du cancer de la prostate localisé à haut risque : mise au point par le Comité Prostate de l'Association française d'urologie.
Prog Urol
; 32(10): 623-634, 2022 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-35644728
6.
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients.
Prog Urol
; 32(6S1): 6S33-6S42, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719645
7.
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?
Prog Urol
; 32(6S1): 6S43-6S53, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719646
8.
[French ccAFU guidelines - update 2020-2022: prostate cancer]. / Recommandations françaises du Comité de cancérologie de l'AFU actualisation 20202022 : cancer de la prostate.
Prog Urol
; 30(12S): S136-S251, 2020 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-33349424
9.
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
J Neurooncol
; 129(1): 85-92, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27169763
10.
Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251].
Prog Urol
; 31(6): 381-382, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941457
11.
The role of radiation therapy for de novo metastatic bladder and renal cancers.
Cancer Radiother
; 28(1): 56-65, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286452
12.
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer.
Cancer Radiother
; 28(1): 49-55, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827959
13.
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.
Eur J Cancer Care (Engl)
; 22(5): 638-47, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23647444
14.
[Limits of dose constraint definition for organs at risk specific to stereotactic radiotherapy]. / Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique.
Cancer Radiother
; 27(4): 341-348, 2023 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-37208260
15.
[Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review]. / Relations entre doses dans les structures anatomiques et dysfonction érectile après radiothérapie pour un cancer de la prostate : revue systématique de la littérature.
Cancer Radiother
; 27(6-7): 548-561, 2023 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-37596125
16.
[Understanding/acceptance of radiotherapy: An ethical dilemma resolved by an ethics of care]. / Compréhension/acceptation de la radiothérapie : un dilemme éthique résolu par une éthique de la considération et de la sollicitude.
Cancer Radiother
; 27(2): 115-125, 2023 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-37011968
17.
[Dose-escalated radiotherapy in esophageal cancer: A review of the literature]. / Escalade de dose dans les cancers de l'Åsophage : revue de la littérature.
Cancer Radiother
; 26(6-7): 884-889, 2022 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-36008261
18.
[The role of proton therapy in esophageal cancer]. / Le rôle de la protonthérapie dans les cancers de l'oesophage.
Cancer Radiother
; 26(4): 604-610, 2022 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-34688549
19.
Radiotherapy for cancers of the oesophagus, cardia and stomach.
Cancer Radiother
; 26(1-2): 250-258, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955417
20.
Dose-escalation in prostate cancer: Results of randomized trials.
Cancer Radiother
; 26(6-7): 899-904, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030191